|
Epigenetic control of cell state in retinoid resistant neuroblastoma |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Effects of standardized, prospective Epstein-Barr virus (EBV) monitoring on the natural history and outcomes of post-transplant lymphoproliferative disorder and EBV-associated smooth muscle tumor in pediatric solid organ transplantation patients |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Identification of phenotypic effects of genomic changes in retinoblastoma tumors using an aqueous humor liquid biopsy |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
|
Incidence and grades of adverse events during treatment for pediatric acute lymphoblastic leukemia |
Emory University |
Northwestern Mutual Foundation |
|
IL7 signaling enhanced CAR T cells to treat pediatric solid tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Arginine Depletion with DFMO in High-Risk Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus |
Northwestern Mutual Foundation |
|
Investigating the Role of the MYCN Oncogene in Regulating Chemokine Expression in Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
